These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27161875)

  • 1. Analysis of the aplyronine A-induced protein-protein interaction between actin and tubulin by surface plasmon resonance.
    Hirayama Y; Yamagishi K; Suzuki T; Kawagishi H; Kita M; Kigoshi H
    Bioorg Med Chem; 2016 Jun; 24(12):2809-14. PubMed ID: 27161875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of photoaffinity derivatives of the antitumor macrolide aplyronine A, a PPI-inducer between actin and tubulin.
    Kita M; Yamagishi K; Tsuchiya K; Seguchi Y; Nakane H; Kigoshi H
    Bioorg Med Chem; 2017 Dec; 25(24):6322-6331. PubMed ID: 29042221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel inducer of protein-protein interactions based on aplyronine A.
    Ohyoshi T; Takano A; Namiki M; Ogura T; Miyazaki Y; Ebihara Y; Takeno K; Hayakawa I; Kigoshi H
    Chem Commun (Camb); 2018 Aug; 54(68):9537-9540. PubMed ID: 30094443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microtubule assembly by a complex of actin and antitumor macrolide aplyronine A.
    Kita M; Hirayama Y; Yoneda K; Yamagishi K; Chinen T; Usui T; Sumiya E; Uesugi M; Kigoshi H
    J Am Chem Soc; 2013 Dec; 135(48):18089-95. PubMed ID: 24228690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel actin depolymerizing macrolide aplyronine A.
    Saito S; Watabe S; Ozaki H; Kigoshi H; Yamada K; Fusetani N; Karaki H
    J Biochem; 1996 Sep; 120(3):552-5. PubMed ID: 8902620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis-inducing activity of the actin-depolymerizing agent aplyronine A and its side-chain derivatives.
    Ohno O; Morita M; Kitamura K; Teruya T; Yoneda K; Kita M; Kigoshi H; Suenaga K
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1467-71. PubMed ID: 23357626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies on an antitumor marine macrolide using aplyronine a-swinholide A hybrid.
    Ohyoshi T; Takano A; Kikuchi I; Ogura T; Namiki M; Miyazaki Y; Hirano T; Konishi S; Ebihara Y; Takeno K; Hayakawa I; Kigoshi H
    Org Biomol Chem; 2022 Apr; 20(14):2922-2938. PubMed ID: 35322840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aplyronine A, a potent antitumour macrolide of marine origin, and the congeners aplyronines B-H: chemistry and biology.
    Yamada K; Ojika M; Kigoshi H; Suenaga K
    Nat Prod Rep; 2009 Jan; 26(1):27-43. PubMed ID: 19374121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the antitumor macrolide aplyronine A with actin and actin-related proteins established by its versatile photoaffinity derivatives.
    Kita M; Hirayama Y; Yamagishi K; Yoneda K; Fujisawa R; Kigoshi H
    J Am Chem Soc; 2012 Dec; 134(50):20314-7. PubMed ID: 23198778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure basis for antitumor effect of aplyronine a.
    Hirata K; Muraoka S; Suenaga K; Kuroda T; Kato K; Tanaka H; Yamamoto M; Takata M; Yamada K; Kigoshi H
    J Mol Biol; 2006 Mar; 356(4):945-54. PubMed ID: 16406066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward aplyronine payloads for antibody-drug conjugates: total synthesis of aplyronines A and D.
    AnŽiček N; Williams S; Housden MP; Paterson I
    Org Biomol Chem; 2018 Feb; 16(8):1343-1350. PubMed ID: 29393939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent aplyronine a: intracellular accumulation and disassembly of actin cytoskeleton in tumor cells.
    Kita M; Yoneda K; Hirayama Y; Yamagishi K; Saito Y; Sugiyama Y; Miwa Y; Ohno O; Morita M; Suenaga K; Kigoshi H
    Chembiochem; 2012 Aug; 13(12):1754-8, 1702. PubMed ID: 22807378
    [No Abstract]   [Full Text] [Related]  

  • 13. Actin-binding marine macrolides: total synthesis and biological importance.
    Yeung KS; Paterson I
    Angew Chem Int Ed Engl; 2002 Dec; 41(24):4632-53. PubMed ID: 12481316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of actin dimerization inducers inspired by actin-depolymerizing macrolides.
    Itakura M; Utomo DH; Kita M
    Chem Commun (Camb); 2024 May; 60(37):4910-4913. PubMed ID: 38623638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Activities of Aplyronine A Analogues toward the Development of Antitumor Protein-Protein Interaction Inducers between Actin and Tubulin: Conjugation of the C1-C9 Macrolactone Part and the C24-C34 Side Chain.
    Futaki K; Takahashi M; Tanabe K; Fujieda A; Kigoshi H; Kita M
    ACS Omega; 2019 May; 4(5):8598-8613. PubMed ID: 31459949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marine natural products that interfere with multiple cytoskeletal protein interactions.
    Kita M; Kigoshi H
    Nat Prod Rep; 2015 Apr; 32(4):534-42. PubMed ID: 25512265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluations of aplyronine A-mycalolide B hybrid compound.
    Kobayashi K; Fujii Y; Hirayama Y; Kobayashi S; Hayakawa I; Kigoshi H
    Org Lett; 2012 Mar; 14(5):1290-3. PubMed ID: 22356580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking and QSAR of aplyronine A and analogues: potent inhibitors of actin.
    Hussain A; Melville JL; Hirst JD
    J Comput Aided Mol Des; 2010 Jan; 24(1):1-15. PubMed ID: 19890607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family of novel actin-inhibiting marine toxins.
    Saito S; Karaki H
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):743-6. PubMed ID: 8886501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin-depolymerizing effect of dimeric macrolides, bistheonellide A and swinholide A.
    Saito SY; Watabe S; Ozaki H; Kobayashi M; Suzuki T; Kobayashi H; Fusetani N; Karaki H
    J Biochem; 1998 Apr; 123(4):571-8. PubMed ID: 9538245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.